Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

4.82
Delayed Data
As of May 27
 +0.08 / +1.69%
Today’s Change
3.70
Today|||52-Week Range
10.40
-40.57%
Year-to-Date

Today’s Trading

Previous close4.74
Today’s open4.70
Day’s range4.65 - 4.82
Volume11,336
Average volume (3 months)42,587
Market cap$101.2M
Dividend yield--
Data as of 3:53pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-19.64%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-30.40%
P/E ratio--
Price/Sales6.97
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...-0.21-2.82%
MRNSMarinus Pharmaceutic...+0.02+0.38%
OHRPOHR Pharmaceutical I...+0.03+0.97%
--EcoGreen Internation...+0.00+2.35%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$20.9M
Annual profit (last year)-$24.5M
Net profit margin-116.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William L. Hunter
Chief Operating Officer
Sheila M. Grant
Corporate headquarters
Vancouver, British Columbia

Forecasts

Partner Offers

Search for Jobs